Aurobindo Infringing Bladder Drug Patent, Astellas Says
Astellas Pharma on Monday accused Aurobindo Pharma Ltd. in Delaware federal court of infringing one of its patents covering the overactive bladder medication VESIcare by applying to make its generic version...To view the full article, register now.
Already a subscriber? Click here to view full article